pentasa 1g modified-release tablets
ferring pharmaceuticals ltd - mesalazine - modified-release tablet - 1gram
menopur 150unit powder and solvent for solution for injection vials
ferring pharmaceuticals ltd - menotrophin - powder and solvent for solution for injection - 150unit
pentasa 4g modified-release granules sachets
ferring pharmaceuticals ltd - mesalazine - modified-release granules - 4gram
menopur 75unit powder and solvent for solution for injection vials
ferring pharmaceuticals ltd - menotrophin - powder and solvent for solution for injection - 75unit
decapeptyl depot 3.75 mg
ferring pharmaceuticals ltd - triptorelin as embonate - powder and solvent for suspension for injection - triptorelin as embonate 3.75 mg ml - triptorelin - triptorelin - - lowering of sexual hormones and - treatment of advanced hormone-dependent prostate cancer. - central precocious puberty.- as adjuvant treatment in combination with tamoxifen or an aromatase inhibitor of hormone receptor-positive early stage breast cancer in women at high risk of recurrence and who are confirmed as pre-menopausal after completion of chemotherapy and in men at high risk of recurrence
ddavp 0.2mg tablets
ferring pharmaceuticals ltd - desmopressin acetate - oral tablet - 200microgram
pentasa 1g suppositories
ferring pharmaceuticals ltd - mesalazine - suppository - 1gram
ddavp 0.1mg tablets
ferring pharmaceuticals ltd - desmopressin acetate - oral tablet - 100microgram
propess 10mg vaginal delivery system
ferring pharmaceuticals ltd - dinoprostone - vaginal device - 10mg
lutigest 100mg vaginal tablets
ferring pharmaceuticals ltd - progesterone - pessary - 100mg